College of American Pathologists
CAP Committees & Leadership CAP Calendar of Events Estore CAP Media Center CAP Foundation
 
About CAP    Career Center    Contact Us      
Search: Search
  [Advanced Search]  
 
CAP Home CAP Advocacy CAP Reference Resources and Publications CAP Education Programs CAP Accreditation and Laboratory Improvement CAP Members
CAP Home > CAP Media Center > CAP News Release Index > National Marrow Donor Program Accepts CAP Accreditation

  Press Release

 

Published on November 17, 2011

Contact: Joe Schramm
Phone: 800-323-4040, ext. 7445
E-mail: media@cap.org

National Marrow Donor Program Accepts CAP Accreditation

Northfield, IL.—The National Marrow Donor Program (NMDP) now recognizes the College of American Pathologists (CAP) Laboratory Accreditation Program for laboratories that need to meet the human leukocyte antigen (HLA) typing accreditation requirement included in the NMDP’s Donor Center Participation Criteria.

HLA, protein markers that are found on most of the body’s cells, are important in matching patients and donors for a bone marrow, peripheral blood cell, or cord blood transplant. When a transplant center looks at matching, it compares how alike the HLA tissue types of the patient and the donor are to each other.

“CAP Accreditation is first and foremost in the interest of patient care,” said Frank R. Rudy, MD, FCAP, Chair, CAP Commission on Laboratory Accreditation. “To deliver the best patient care, we collaborate with many organizations to provide the highest quality standards in laboratory testing and strive to offer our gold standard program to organizations, like NMDP, that establish specialized laboratory-testing criteria.”

As part of the CAP accreditation process, inspectors examine the laboratory’s records and quality control procedures for the preceding two years. CAP inspectors examine the entire staff’s qualifications, equipment, facilities, safety program and record, and overall laboratory management. The inspection program is designed to ensure the highest standard of care for the laboratory’s patients.

In addition to CAP Accreditation, the NMDP accepts accreditation for HLA typing from the American Society for Histocompatibility and Immunogenetics (ASHI) and the European Federation for Immunogenetics (EFI). In 2006, the United Network for Organ Sharing (UNOS) recognized the CAP Accreditation Program as an approved accrediting body for laboratories in its Organ Procurement and Transplantation Network. UNOS recognizes ASHI, too.

The Centers for Medicare and Medicaid Services (CMS), which granted the CAP deeming authority, recognizes CAP Laboratory Accreditation Program as being equal to or more stringent than the government’s own inspection program. The Joint Commission also recognizes the CAP program that can be used to meet many state certification requirements. The CAP also provides laboratory accreditation to forensic drug testing and reproductive laboratories, co-sponsored with the American Society for Reproductive Medicine (ASRM).

“The spirit of these co-sponsorships and collaborations is to apply scientific knowledge and advice from our health care colleagues to enhance the accreditation process,” said Stanley J. Robboy, MD, FCAP, CAP President. “The CAP will continue to reach out to other organizations as it enhances current accreditation programs and develops new ones.”

The College of American Pathologists (CAP), celebrating 50 years as the gold standard in laboratory accreditation, is a medical society serving more than 17,000 physician members and the global laboratory community. It is the world’s largest association composed exclusively of board-certified pathologists and is the worldwide leader in laboratory quality assurance. The College advocates accountable, high-quality, and cost-effective patient care.

 
 

 

 

   
 
 © 2014 College of American Pathologists. All rights reserved. | Terms and Conditions | CAP ConnectFollow Us on FacebookFollow Us on LinkedInFollow Us on TwitterFollow Us on YouTubeFollow Us on FlickrSubscribe to a CAP RSS Feed